Zurich Insurance Group LTD Gilead Sciences, Inc. Transaction History

Zurich Insurance Group LTD

$11.3 Billion
Q2 2024

A detailed history of Zurich Insurance Group LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Zurich Insurance Group LTD holds 30,700 shares of GILD stock, worth $2.58 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

30,700

Previous 30,700 -0.0%

Holding current value

$2.58 Million

Previous $2.25 Million 6.32%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $2.27 Million - $2.48 Million	30,700 New	30,700 $2.3 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $1.38 Million - $1.55 Million	23,900 New	23,900 $1.48 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $15.8 Million - $17.4 Million	-256,609 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $536,273 - $591,951	8,579 Added 3.46%	256,609 $16.3 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $2.54 Million - $2.85 Million	41,097 Added 19.86%	248,030 $16.8 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $2.57 Million - $2.88 Million	-41,127 Reduced 16.58%	206,933 $13.5 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $214,432 - $279,818	3,542 Added 1.45%	248,060 $15.5 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $1.92 Million - $2.12 Million	26,871 Added 12.35%	244,518 $18.9 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $1.71 Million - $1.99 Million	-26,357 Reduced 10.8%	217,647 $15.4 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $4.15 Million - $5.06 Million	56,961 Added 30.45%	244,004 $18.4 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $1.53 Million - $1.79 Million	21,488 Added 12.98%	187,043 $13.4 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $11.9 Million - $14.1 Million	165,555	165,555 $13.4 Million

Others Institutions Holding GILD

# of Institutions

1,880

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurich Insurance Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Zurich Insurance Group LTD with notifications on news.

Account

Zurich Insurance Group LTD Gilead Sciences, Inc. Transaction History